Zealand Pharma stock forecast
Zealand Pharma (ZLDPF) Stock Forecast & Price Target
ZLDPF Analyst Ratings
ZLDPF Stock 12 Month Forecast
Average Price Target
$57.15▲(60.16% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Yihan Li | Barclays | $63.50→$49.31 | hold | 38.18%Upside | Downgraded | 09/08/26 | ||
| Sophia Graeff Buhl-Nielsen | J.P. Morgan | $68.73→$65.00 | buy | 82.15%Upside | Reiterated | 08/25/26 | ||
| Benjamin Jackson CFA | Jefferies | $75.46→$47.82 | hold | 33.99%Upside | Downgraded | 07/13/26 | ||
| Kerry Holford | Berenberg Bank | $123.27→$44.83 | hold | 25.62%Upside | Downgraded | 06/16/26 | ||
| Emmanuel Papadakis | Deutsche Bank | $41.09→$44.83 | hold | 25.62%Upside | Reiterated | 06/04/26 | ||
| Xian Deng | UBS | $109.08 | buy | 205.67%Upside | Reiterated | 05/08/26 | ||
| Thomas Bowers | SEB Enskilda | $56.78→$70.98 | buy | 98.89%Upside | Upgraded | 04/29/26 | ||
| Martin Brenoe | Nordea Markets | ― | hold | ― | Downgraded | 03/06/26 | ||
| Prakhar Agrawal | Cantor Fitzgerald | ― | hold | ― | Downgraded | 03/06/26 | ||
| Andy Hsieh | William Blair | ― | hold | ― | Downgraded | 03/06/26 | ||
| Kirsty Ross Stewart | Exane BNP Paribas | $41.09 | hold | 15.15%Upside | Downgraded | 03/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Yihan LiBarclays | HoldDowngraded$63.50→$49.31 | 09/08/26 | 38.18%Upside | ||
| Sophia Graeff Buhl-NielsenJ.P. Morgan | BuyReiterated$68.73→$65.00 | 08/25/26 | 82.15%Upside | ||
| Benjamin Jackson CFAJefferies | HoldDowngraded$75.46→$47.82 | 07/13/26 | 33.99%Upside | ||
| Kerry HolfordBerenberg Bank | HoldDowngraded$123.27→$44.83 | 06/16/26 | 25.62%Upside | ||
| Emmanuel PapadakisDeutsche Bank | HoldReiterated$41.09→$44.83 | 06/04/26 | 25.62%Upside | ||
| Xian DengUBS | BuyReiterated$109.08 | 05/08/26 | 205.67%Upside | ||
| Thomas BowersSEB Enskilda | BuyUpgraded$56.78→$70.98 | 04/29/26 | 98.89%Upside | ||
| Martin BrenoeNordea Markets | HoldDowngraded | 03/06/26 | ― | ||
| Prakhar AgrawalCantor Fitzgerald | HoldDowngraded | 03/06/26 | ― | ||
| Andy HsiehWilliam Blair | HoldDowngraded | 03/06/26 | ― | ||
| Kirsty Ross StewartExane BNP Paribas | HoldDowngraded$41.09 | 03/06/26 | 15.15%Upside |
Best Analysts Covering Zealand Pharma
Copying Thomas Bowers's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.05% per trade.
Copying Thomas Bowers's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.00% per trade.
Copying Thomas Bowers's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -6.00% per trade.
ZLDPF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 4 | 3 | 2 | 1 |
In the current month, ZLDPF has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ZLDPF average Analyst price target in the past 3 months is 57.15.
ZLDPF Financial Forecast
ZLDPF Earnings Forecast
Next quarter’s earnings estimate for ZLDPF is -$2.09 with a range of -$2.89 to -$1.50. The previous quarter’s EPS was -$0.12. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ZLDPF Sales Forecast
Next quarter’s sales forecast for ZLDPF is $2.55M with a range of $0 to $9.79M. The previous quarter’s sales results were $589.84K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

